Published in Arch Pathol Lab Med on August 01, 1992
Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood. Am J Pathol (1995) 3.37
Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome? Br J Cancer (2001) 3.23
Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group. Am J Pathol (2009) 2.14
Favorable vs unfavorable histologic appearance. The lexicon of pathologic grading of solid malignant neoplasms in children. Arch Pathol Lab Med (1992) 1.64
Rhabdomyosarcoma in adolescent and young adult patients: current perspectives. Adolesc Health Med Ther (2014) 1.28
Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass. Am J Pathol (2000) 1.18
Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Am J Clin Pathol (2013) 1.18
Multiplex RT-PCR assay for the differential diagnosis of alveolar rhabdomyosarcoma and Ewing's sarcoma. Am J Pathol (1995) 1.13
Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma. Neoplasia (1999) 1.06
PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma. Am J Pathol (2001) 1.06
Amplification of the t(2; 13) and t(1; 13) translocations of alveolar rhabdomyosarcoma in small formalin-fixed biopsies using a modified reverse transcriptase polymerase chain reaction. Am J Pathol (1997) 1.05
Rhabdomyosarcoma of mandible: A diagnostic predicament. J Oral Maxillofac Pathol (2011) 0.96
Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations. Virchows Arch (2009) 0.93
Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group. Am J Surg Pathol (2014) 0.92
Advantage of FISH analysis using FKHR probes for an adjunct to diagnosis of rhabdomyosarcomas. Virchows Arch (2008) 0.86
Dystrophin and dysferlin double mutant mice: a novel model for rhabdomyosarcoma. Cancer Genet (2012) 0.84
Rhabdomyosarcomas: an overview on the experimental animal models. J Cell Mol Med (2012) 0.84
Spindle cell embryonal rhabdomyosarcoma of the prostate in an adult patient - case report and review of clinicopathological features. Diagn Pathol (2016) 0.75
All histological types of primary human rhabdomyosarcoma express alpha-cardiac and not alpha-skeletal actin messenger RNA. Am J Pathol (1994) 0.75
Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol (1998) 5.74
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol (1989) 5.44
Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med Phys (1994) 4.50
The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med (1989) 4.24
Of scientific physicians and evidence-based medicine. Int J Radiat Oncol Biol Phys (2001) 3.94
High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res (1998) 3.56
Endotoxemia in human septic shock. Chest (1991) 3.52
Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med (1995) 3.43
Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol (2000) 3.35
Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma Study. Cancer (1995) 3.11
The value of laparotomy and splenectomy in the staging of Hodgkin's disease. Cancer (1969) 2.93
Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol (1994) 2.59
Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma. J Clin Oncol (2001) 2.55
Surgical staging of abdominal involvement in unselected patients with Hodgkin's disease. Radiology (1970) 2.16
Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol (1997) 2.15
MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol (1997) 2.02
Is meta-analysis really meta-physics? Chest (1999) 2.00
Is primitive neuroectodermal tumor of the kidney a distinct entity? Cancer (1997) 1.99
The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer (1984) 1.93
Patterns of recurrence in patients with high-grade soft-tissue sarcomas. J Clin Oncol (1985) 1.87
Alveolar soft part sarcoma in children and adolescents: clinical features and outcome of 11 patients. Med Pediatr Oncol (1996) 1.85
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res (1996) 1.82
Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med (1979) 1.79
Intraoperative photodynamic therapy for malignant mesothelioma. Ann Thorac Surg (1990) 1.77
Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer (2004) 1.75
Clinicopathologic studies of 117 untreated patients subjected to laparotomy for the staging of Hodgkin's disease. Cancer (1971) 1.74
Dose-intensive induction therapy with cyclophosphamide, cisplatin, and consolidative abdominal radiation in advanced-stage epithelial ovarian cancer. J Clin Oncol (1992) 1.74
Long-term follow-up of Ewing's sarcoma of bone treated with combined modality therapy. Int J Radiat Oncol Biol Phys (1991) 1.70
Experimental evidence for a neural origin of Ewing's sarcoma of bone. Am J Pathol (1987) 1.68
Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft. Diabetologia (2009) 1.65
A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet Cell Genet (1987) 1.60
Intravenous recombinant interferon beta in patients with recurrent malignant gliomas: a phase I/II study. J Clin Oncol (1991) 1.60
Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody. J Clin Invest (1983) 1.59
Vasospastic elements in myocardial infarction following coronary occlusion in the dog. Cardiovasc Res (1968) 1.55
Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation. Am J Pathol (1994) 1.55
Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. J Clin Oncol (1984) 1.55
Myocardial vascular reactivity after beta-adrenergic blockade. Lancet (1966) 1.55
Comparison between isotropic and nonisotropic dosimetry systems during intraperitoneal photodynamic therapy. Lasers Surg Med (2000) 1.54
Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus. Am J Med (1980) 1.53
Correlation of pathologic features with clinical outcome in pediatric adrenocortical neoplasia. A study of a Brazilian population. Brazilian Group for Treatment of Childhood Adrenocortical Tumors. Am J Clin Pathol (1994) 1.53
Natural language generation in health care. J Am Med Inform Assoc (1997) 1.51
Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. J Clin Oncol (1987) 1.50
Part-of relations in anatomy ontologies: a proposal for RDFS and OWL formalisations. Pac Symp Biocomput (2004) 1.50
Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol (1999) 1.48
Continuous intravenous infusion of morphine sulfate for control of severe pain in children with terminal malignancy. J Pediatr (1980) 1.45
Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial. J Clin Oncol (1991) 1.44
Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood (2001) 1.44
Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. J Pediatr Surg (2000) 1.43
Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol (1999) 1.43
Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility. Cancer Res (1992) 1.43
Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg (1993) 1.41
Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: impact on the delivery of local-regional radiation therapy. Ann Oncol (1999) 1.40
Peripheral primitive neuroectodermal tumor (peripheral neuroepithelioma) in children. A review of the St. Jude experience and controversies in diagnosis and management. Cancer (1989) 1.40
Is renal salvage feasible in unilateral Wilms' tumor? Proposed computed tomographic criteria and their relation to surgicopathologic findings. Am J Pediatr Hematol Oncol (1990) 1.38
Chemosensitivity testing of human lung cancer cell lines using the MTT assay. Br J Cancer (1988) 1.35
Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma. Am J Pathol (1990) 1.34
Tempol, a stable free radical, is a novel murine radiation protector. Cancer Res (1992) 1.34
Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I study. Arch Surg (1991) 1.34
Diffuse fasciitis with eosinophilia. A clinicopathologic study. Am J Med (1980) 1.31
Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. Surgery (1985) 1.30
Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial. Ann Intern Med (1987) 1.30
Accuracy of MR imaging for estimating intraosseous extent of osteosarcoma. AJR Am J Roentgenol (1996) 1.29
Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int J Radiat Oncol Biol Phys (1993) 1.28
Small cell lung cancer 1973-1983: early progress and recent obstacles. Int J Radiat Oncol Biol Phys (1984) 1.27
The effects of carbochromen on myocardial blood flow and metabolic heat production before and after acute coronary ligation. Br J Pharmacol (1969) 1.27
Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions. Adv Pharmacol Chemother (1984) 1.25
Photodynamic therapy. J Clin Oncol (1988) 1.25
Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest (1997) 1.24
Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report. J Pediatr Hematol Oncol (2001) 1.24
Photodynamic therapy of cancer. Compr Ther (1988) 1.24
Treatment of peripheral neuroepithelioma in children and young adults. J Clin Oncol (1987) 1.24
Prospective randomized evaluation of the role of limb-sparing surgery, radiation therapy, and adjuvant chemoimmunotherapy in the treatment of adult soft-tissue sarcomas. Surgery (1978) 1.23
Photodynamic therapy in the treatment of cancer: current state of the art. Drugs (1999) 1.22
Observations on the mechanisms of infarction in the dog after experimental occlusion of the coronary artery. Lancet (1966) 1.22
Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups. Ann Intern Med (1988) 1.20
Detection of mutant Ha-ras genes in chemically initiated mouse skin epidermis before the development of benign tumors. Proc Natl Acad Sci U S A (1992) 1.20
Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin's lymphomas. Cancer Treat Rep (1977) 1.19
High-grade soft tissue sarcomas of the extremities. Cancer (1986) 1.18
The effects of amyl nitrite inhalation on myocardial blood flow and metabolic heat production. Br J Pharmacol Chemother (1967) 1.17
Characterization of cell lines derived from xenografts of childhood rhabdomyosarcoma. Cancer Res (1987) 1.17
Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation. Bone Marrow Transplant (2006) 1.15
Sarcomas (other than Ewing's) of flat bones in children and adolescents. A clinicopathologic study. Cancer (1990) 1.15
Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region. Cancer Res (2000) 1.15
Neurologic, neuropsychologic, and computed cranial tomography scan abnormalities in 2- to 10-year survivors of small-cell lung cancer. J Clin Oncol (1985) 1.15
The Evi-1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes. Oncogene (1990) 1.15
Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial. J Clin Oncol (2001) 1.15
CT-pathologic correlations in Hodgkin's disease and non-Hodgkin's lymphoma. Radiology (1978) 1.15
TBI during BM and SCT: review of the past, discussion of the present and consideration of future directions. Bone Marrow Transplant (2010) 1.15
Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer (1983) 1.14
The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment. Semin Hematol (1988) 1.14